Jonosteril D5 (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glu)

The solution provides essential ions and glucose directly into the bloodstream, expanding extracellular fluid volume and restoring osmotic equilibrium. The supplied electrolytes participate in nerve conduction, muscle contraction and enzymatic reactions, while glucose supplies immediate metabolic energy, together normalising the patient’s fluid‑electrolyte status.

The dose of Jonosteril D5 is determined by the prescribing clinician based on the patient’s weight, clinical condition, electrolyte levels and fluid losses. Healthcare professionals calculate the appropriate volume and rate of infusion to safely achieve the desired fluid and electrolyte replacement.

Safety data for Jonosteril D5 in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Jonosteril D5, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Jonosteril D5 offers a balanced combination of sodium, potassium, calcium, magnesium and glucose in a single formulation, which can reduce the need for multiple separate infusions. Compared with simpler saline solutions, it addresses a broader range of electrolyte deficits and provides an energy source, making it suitable for complex fluid‑replacement scenarios.

Jonosteril D5 must be stored at 2‑8 °C, protected from light, and should never be frozen or shaken. Keep the product in its original packaging until use and discard any solution that appears discoloured or contains particles.

Jonosteril D5 is administered intravenously. The solution is typically infused through a peripheral or central venous line, with the rate and total volume determined by the clinician based on the patient’s fluid status, electrolyte measurements and overall clinical picture.

Serious risks include severe electrolyte disturbances that can lead to cardiac arrhythmias, anaphylactic reactions, pulmonary edema from fluid overload, and metabolic acidosis. Continuous monitoring of vital signs, electrolyte levels and fluid balance is essential to mitigate these risks.

Jonosteril D5 should be avoided in patients with known hypersensitivity to any of its components, in those with uncontrolled hyperkalemia or hypercalcemia, and in individuals where fluid overload could exacerbate heart failure or severe renal impairment unless closely monitored by a physician.